Roche’s antiviral hits flu targets in PhIII trial

Roche’s antiviral hits flu targets in PhIII trial

Source: 
Pharma Times
snippet: 

Roche says its investigational flu drug baloxavir marboxil, in-licensed from Japan’s Shionogi, has met key goals in a late-stage trial.